Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BLDR

Go back to Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview

Acadia Pharma (ACAD) Tops Q3 EPS by 5c, Beats on Revenue, Offers Guidance

November 2, 2023 4:13 PM EDT

Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.40), $0.05 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $211.7 million versus the consensus estimate of $192.2 million.

For FY23 the company guides:

NUPLAZID net sales in the range of... More